Published in J Rheumatol on October 01, 1987
Monocyte activation in early onset rheumatoid arthritis. Ann Rheum Dis (1990) 0.90
Inhibition of human monocyte adhesion to endothelial cells by the coumarin derivative, cloricromene. Br J Pharmacol (1994) 0.76
Chemokine networks in vivo: involvement of C-X-C and C-C chemokines in neutrophil extravasation in vivo in response to TNF-alpha. J Immunol (1997) 2.51
Expression of the cytokine RANTES in human rheumatoid synovial fibroblasts. Differential regulation of RANTES and interleukin-8 genes by inflammatory cytokines. J Biol Chem (1993) 2.06
Non-secretion of ABO blood group antigens as a host susceptibility factor in the spondyloarthropathies. Br Med J (Clin Res Ed) (1987) 1.91
Bronchodilatation after inhalation of the antihistamine clemastine. Thorax (1978) 1.76
Health economics as an aspect of health outcome: basic principles and application in rheumatoid arthritis. Br J Rheumatol (1995) 1.43
Measuring health status in British patients with rheumatoid arthritis: reliability, validity and responsiveness of the short form 36-item health survey (SF-36). Br J Rheumatol (1998) 1.38
Is day care equivalent to inpatient care for active rheumatoid arthritis? Randomised controlled clinical and economic evaluation. BMJ (1998) 1.35
Depression of lymphocyte responses after surgical trauma. Br J Exp Pathol (1973) 1.29
Chemokines: extracellular messengers for all occasions? Bioessays (1999) 1.23
Monosodium urate microcrystals induce cyclooxygenase-2 in human monocytes. Blood (1998) 1.20
CC chemokine ligand-5 (CCL5/RANTES) and CC chemokine ligand-18 (CCL18/PARC) are specific markers of refractory unstable angina pectoris and are transiently raised during severe ischemic symptoms. Circulation (2007) 1.17
Regulation of chemokine gene expression in human peripheral blood neutrophils phagocytosing microbial pathogens. J Immunol (1998) 1.14
Engagement of major histocompatibility complex class II molecules by superantigen induces inflammatory cytokine gene expression in human rheumatoid fibroblast-like synoviocytes. J Exp Med (1992) 1.09
Expression and activity of prostaglandin endoperoxide synthase-2 in agonist-activated human neutrophils. FASEB J (1998) 1.07
Induction of acute inflammation in vivo by staphylococcal superantigens. II. Critical role for chemokines, ICAM-1, and TNF-alpha. J Immunol (1998) 1.07
Chemokine receptors CXCR4 and CCR7 promote metastasis by preventing anoikis in cancer cells. Cell Death Differ (2009) 1.07
Selective inhibition of human neutrophil functional responsiveness by erbstatin, an inhibitor of tyrosine protein kinase. Blood (1990) 1.07
Translocation of protein kinase C to a Triton-insoluble sub-cellular compartment induced by the lipophilic gold compound auranofin. Biochem Pharmacol (1988) 1.06
Differential expression of two major cytokines produced by neutrophils, interleukin-8 and the interleukin-1 receptor antagonist, in neutrophils isolated from the synovial fluid and peripheral blood of patients with rheumatoid arthritis. Arthritis Rheum (1994) 1.06
Stimulation of human neutrophils by chemotactic factors is associated with the activation of phosphatidylinositol 3-kinase gamma. J Biol Chem (2000) 1.05
Production of monocyte chemotactic protein-1 in human type B synoviocytes. Synergistic effect of tumor necrosis factor alpha and interferon-gamma. Arthritis Rheum (1993) 1.04
Colocalization of cytosolic phospholipase A2, 5-lipoxygenase, and 5-lipoxygenase-activating protein at the nuclear membrane of A23187-stimulated human neutrophils. Eur J Biochem (1996) 1.04
Uptake of chloroquine and hydroxychloroquine by human blood leucocytes in vitro: relation to cellular concentrations during antirheumatic therapy. Ann Rheum Dis (1987) 1.02
Activation of the human neutrophil 5-lipoxygenase by leukotriene B4. Br J Pharmacol (1992) 1.01
Nuclear signaling in human neutrophils. Stimulation of RNA synthesis is a response to a limited number of proinflammatory agonists. J Biol Chem (1992) 1.01
Modulation by phorbol myristate acetate of arachidonic acid release and leukotriene synthesis by human polymorphonuclear leukocytes stimulated with A23187. Biochem Biophys Res Commun (1986) 1.00
Granulocyte/macrophage colony-stimulating factor stimulates the expression of the 5-lipoxygenase-activating protein (FLAP) in human neutrophils. J Exp Med (1994) 0.98
Differential roles for the p101 and p84 regulatory subunits of PI3Kγ in tumor growth and metastasis. Oncogene (2011) 0.98
Zinc increases phorbol ester receptors in intact B-cells, neutrophil polymorphs and platelets. FEBS Lett (1989) 0.98
Molecular basis of activation and regulation of the phagocyte respiratory burst. Ann Rheum Dis (1987) 0.96
Genomic organization and biological characterization of the novel human CC chemokine DC-CK-1/PARC/MIP-4/SCYA18. Genomics (1999) 0.96
Tyrosine phosphorylation in activated human neutrophils. Comparison of the effects of different classes of agonists and identification of the signaling pathways involved. J Immunol (1994) 0.96
Identification of G-protein binding sites of the human interleukin-8 receptors by functional mapping of the intracellular loops. FASEB J (1996) 0.95
Evidence for defect of complement-mediated phagocytosis by monocytes from patients with rheumatoid arthritis and cutaneous vasculitis. Br Med J (Clin Res Ed) (1981) 0.94
Is chronic renal failure a risk factor for the development of erosive osteoarthritis? Ann Rheum Dis (1989) 0.93
Coxsackie B infection and arthritis. Br Med J (Clin Res Ed) (1983) 0.93
Physical association of Gi2alpha with interleukin-8 receptors. J Biol Chem (1996) 0.93
Differential effects of mepacrine, chloroquine and hydroxychloroquine on superoxide anion generation, phospholipid methylation and arachidonic acid release by human blood monocytes. Biochem Pharmacol (1986) 0.92
Characterization of the priming effects of human granulocyte-macrophage colony-stimulating factor on human neutrophil leukotriene synthesis. Prostaglandins (1988) 0.91
Arachidonic acid-induced mobilization of calcium in human neutrophils: evidence for a multicomponent mechanism of action. Br J Pharmacol (1989) 0.91
Granulocyte-macrophage colony-stimulating factor enhances 5-lipoxygenase levels in human polymorphonuclear leukocytes. J Immunol (1994) 0.91
Regulation of stimulated integrin surface expression in human neutrophils by tyrosine phosphorylation. Blood (1994) 0.91
An arthrogenic alphavirus induces monocyte chemoattractant protein-1 and interleukin-8. Intervirology (2000) 0.90
Autocrine enhancement of leukotriene synthesis by endogenous leukotriene B4 and platelet-activating factor in human neutrophils. Br J Pharmacol (1994) 0.90
Synergistic effect of interleukin-1 beta and tumor necrosis factor alpha on interleukin-8 gene expression in synovial fibroblasts. Evidence that interleukin-8 is the major neutrophil-activating chemokine released in response to monokine activation. Arthritis Rheum (1993) 0.88
Propionic acid-induced calcium mobilization in human neutrophils. J Cell Physiol (1988) 0.88
Diverging signal transduction pathways activated by interleukin 8 (IL-8) and related chemokines in human neutrophils. IL-8 and Gro-alpha differentially stimulate calcium influx through IL-8 receptors A and B. J Biol Chem (1996) 0.87
Chemoattractant-induced cytoplasmic pH changes and cytoskeletal reorganization in human neutrophils. Relationship to the stimulated calcium transients and oxidative burst. J Immunol (1989) 0.87
A pilot study of the economic cost and clinical outcome of day patient vs inpatient management of active rheumatoid arthritis. Br J Rheumatol (1994) 0.86
Production of chemokines in vivo in response to microbial stimulation. J Immunol (2001) 0.86
Studies on the activation of human neutrophil 5-lipoxygenase induced by natural agonists and Ca2+ ionophore A23187. Biochem J (1991) 0.86
Functional defects of monocyte C3b receptor-mediated phagocytosis in rheumatoid arthritis (RA): evidence for an association with the appearance of a circulating population of non-specific esterase-negative mononuclear phagocytes. Ann Rheum Dis (1983) 0.85
Induction by chemokines of lipid mediator synthesis in granulocyte-macrophage colony-stimulating factor-treated human neutrophils. J Immunol (1993) 0.85
Studies of the effect of D-penicillamine and sodium aurothiomalate therapy on superoxide anion production by monocytes from patients with rheumatoid arthritis: evidence for in vivo stimulation of monocytes. Ann Rheum Dis (1986) 0.84
Evidence for intrinsic cellular defects of 'complement' receptor-mediated phagocytosis in patients with systemic lupus erythematosus (SLE). Clin Exp Immunol (1984) 0.84
Up-regulation by tumor necrosis factor alpha of intercellular adhesion molecule 1 expression and function in synovial fibroblasts and its inhibition by glucocorticoids. Arthritis Rheum (1993) 0.84
Wegener's granulomatosis complicated by diabetes insipidus. Ann Rheum Dis (1983) 0.84
Up-regulation of the amount of Gi alpha 2 associated with the plasma membrane in human neutrophils stimulated by granulocyte-macrophage colony-stimulating factor. Biochem J (1993) 0.84
Inhibition of epidermal growth factor binding to HeLa cells by auranofin. Biochem Pharmacol (1987) 0.83
Calcium ionophore A23187 enhances human neutrophil superoxide release, stimulated by phorbol dibutyrate, by converting phorbol ester receptors from a low- to high-affinity state. FEBS Lett (1987) 0.83
Induction of acute inflammation in vivo by staphylococcal superantigens I: Leukocyte recruitment occurs independently of T lymphocytes and major histocompatibility complex Class II molecules. Lab Invest (1998) 0.82
Evidence for a role for SAM68 in the responses of human neutrophils to ligation of CD32 and to monosodium urate crystals. J Immunol (2001) 0.82
Medically unexplained symptoms in patients referred to a specialist rheumatology service: prevalence and associations. Rheumatology (Oxford) (2003) 0.82
Quantifying the burden of emotional ill-health amongst patients referred to a specialist rheumatology service. Rheumatology (Oxford) (2003) 0.81
Auranofin stimulates LTA hydrolase and inhibits 5-lipoxygenase/LTA synthase activity of isolated human neutrophils. Biochem Pharmacol (1990) 0.81
An audit of methotrexate and folic acid for rheumatoid arthritis. Experience from a teaching centre. Br J Rheumatol (1995) 0.81
Contrasting roles for RANTES and macrophage inflammatory protein-1 alpha (MIP-1 alpha) in a murine model of allergic peritonitis. Clin Exp Immunol (1999) 0.81
Murine chemokine gene expression in rejecting pig proislet xenografts. Transplant Proc (2000) 0.81
Cervical spine surgery in patients with rheumatoid arthritis: an appraisal. Ann Rheum Dis (1996) 0.81
Determination of 5-lipoxygenase activity in human polymorphonuclear leukocytes using high-performance liquid chromatography. J Chromatogr (1986) 0.81
Monocyte superoxide anion production in rheumatoid arthritis: preliminary evidence for enhanced rates of superoxide anion production by monocytes from patients receiving penicillamine, sodium aurothiomalate and corticosteroids. Ann Rheum Dis (1984) 0.81
Inhibition of lymphocyte adhesion to cytokine-activated synovial fibroblasts by glucocorticoids involves the attenuation of vascular cell adhesion molecule 1 and intercellular adhesion molecule 1 gene expression. Arthritis Rheum (1996) 0.80
An evaluation of the Health Assessment Questionnaire (HAQ) in a long-term longitudinal follow-up of disability in rheumatoid arthritis. Br J Rheumatol (1994) 0.80
IgG (kappa) paraproteinaemia and arthritis. Br J Rheumatol (1987) 0.80
Increased monocyte chemotactic protein-1 level and activity in the peripheral blood of women with endometriosis. Le Groupe d'Investigation en Gynécologie. Am J Obstet Gynecol (1996) 0.80
Effect of dietary polyunsaturated fatty acid (PUFA) supplementation on adjuvant induced polyarthritis in rats. J Rheumatol (1987) 0.79
Inhibition of protein kinase C activity by the antirheumatic drug auranofin. Biochem Pharmacol (1989) 0.78
Interleukin-4 and nerve growth factor can act as cofactors for interleukin-3-induced histamine production in human umbilical cord blood cells in serum-free culture. Br J Haematol (1992) 0.78
Scleroderma renal crisis: poor outcome despite aggressive antihypertensive treatment. Intern Med J (2003) 0.78
Enhancement of protein kinase C-mediated EGF receptor phosphorylation by auranofin. Scand J Rheumatol (1988) 0.78
Genomic organization of the CC chemokine mip-3alpha/CCL20/larc/exodus/SCYA20, showing gene structure, splice variants, and chromosome localization. Genomics (2001) 0.78
Transient presence in serum of an atypical alkaline phosphatase. Clin Chim Acta (1976) 0.78
C2-ceramide primes specifically for the superoxide anion production induced by N-formylmethionylleucyl phenylalanine (fMLP) in human neutrophils. Biochim Biophys Acta (1996) 0.78
Toxocara canis larval excretory/secretory proteins impair eosinophil-dependent resistance of mice to Nippostrongylus brasiliensis. Parasite Immunol (2008) 0.78
Premature development of erosive osteoarthritis of hands in patients with chronic renal failure. Ann Rheum Dis (1990) 0.77
Re: Quality of life measures. Br J Rheumatol (1997) 0.77
Sjögren's syndrome, vasculitis, and cryoglobulinaemia associated with a monoclonal IgM (kappa) paraprotein with rheumatoid factor activity. Ann Rheum Dis (1987) 0.77
Granulocyte-macrophage colony-stimulating factor enhances EBV-induced synthesis of chemotactic factors in human neutrophils. J Immunol (1998) 0.77
Intestinal cholesterol uptake from phospholipid vesicles and from simple and mixed micelles. Lipids (1981) 0.77
Decline in hand bone mineral density indicates increased risk of erosive change in early rheumatoid arthritis. Arthritis Care Res (Hoboken) (2014) 0.77
Does economic evaluation have anything to offer the rheumatologist? Rheumatology (Oxford) (1999) 0.76
Reactive arthritis--infectious agents and genetic susceptibility in the pathogenesis of sero-negative arthritis. Scott Med J (1983) 0.76
Auranofin increases the affinity of phorbol dibutyrate receptors in chronic lymphocytic leukemia cells (B cells). J Immunol (1987) 0.76
Screening for antimalarial maculopathy in rheumatology clinics. Br Med J (Clin Res Ed) (1985) 0.75
Re: Measuring outcomes in rheumatoid arthritis--which measures are suitable for routine use? Br J Rheumatol (1997) 0.75
Sclerosing injections in patients with chronic low back pain. Rheumatology (Oxford) (2000) 0.75